Aligning Science Across Parkinson's Logo Text

PD Heterogeneity Archive

Submit site search
  • Berit Andres, MSc

    Berit Andres is a PhD student with Andreas Keller at the Chair of Clinical Bioinformatics, Saarland University (Germany). She obtained her Master’s degree in Bioinformatics from Saarland University, working on the analysis of Parkinson’s disease progression using longitudinal blood transcriptomics.

  • Monther Abu-Remaileh, PhD

    Monther Abu-Remaileh, PhD, is an assistant professor of chemical engineering and by courtesy of genetics at Stanford University. He is an expert in lysosome biology and metabolism, and his team develops and uses multidisciplinary approaches, including metabolomics, proteomics and functional genomics, to study the biochemical functions of the lysosome. His lab is committed to applying these tools to provide molecular understanding of the lysosomal dysfunction in Parkinson's disease, which has been implicated in disease pathology. Dr. Abu-Remaileh earned his B.Sc. in Genetics from Jordan University of Science and Technology and his doctorate from the Hebrew University of Jerusalem and then completed his postdoctoral training at MIT.

  • Daniel El Kodsi, PhD

    During Daniel's scientific training as a neuroscientist, under Dr. Michael Schlossmacher, he focused on the pathogenesis of early-onset parkinsonism. He was able to: (i) investigate the PD pathogenesis and delineate disease mechanisms; (ii) build animal models to restage PD gene-linked neural degeneration; and (i) delineate Parkin-related cellular mechanisms using both cell and protein modelling. These efforts culminated in the discovery of a novel antioxidant function for wild-type parkin in human brain. Transitioning into more clinical work, he focused on COVID-19 research, sero-surveillance and prevalence, under the supervision of Dr. Amy Hsu. As a clinical research program manager he was tasked with: (i) assessing SARS-CoV-2 infection, re-infection, and serious outcomes in Long-Term Care (LTC) sector; (ii) investigating natural and vaccine-induced immunity; and (iii) building prediction models for SARS-CoV-2. This allowed him to harness high-level project management skills.

  • Shaline Fazal, PhD

    Shaline is a postdoctoral researcher at the University of Cambridge. She has been involved in various projects focused around several aspects of Parkinson's disease.

  • Zane Jaunmuktane, MD

    Zane Jaunmuktane is a Clinical Lecturer and Honorary Consultant Neuropathologist at the Queen Square Brain Bank for Neurological Disorders and in the Division of Neuropathology, Department of Clinical and Movement Neurosciences, University College London. Together with colleagues, she was the first to demonstrate that under certain circumstances, amyloid-beta pathology is transmissible in humans. Zane's main interest is in the cell-to-cell spreading and regional propagation mechanisms of misfolded proteins and how concomitant pathologies determine disease progression and symptom severity.

  • Sara Salama, PhD

    Sara graduated as a pharmacist from King Saud University, Riyadh, Saudi Arabia in 2016. She obtained her PhD in Molecular Immunology from KU Leuven in 2021. Afterwards, she went on to perform post-doctoral research as a fellow of the FWO (Research Foundation Flanders) in the Rega Institute for Medical research. Her research interests are primarily focused on characterizing the biological activity of the acute phase protein, serum amyloid A in relation to its capacity to regulate leukocyte function. Moreover, she is involved in characterizing the post translationally modified variants of inflammatory proteins.

  • Laura Castilla-Vallmanya, PhD

    Laura is a postdoctoral researcher at Lund University (Sweden). She obtained her PhD in Genetics from University of Barcelona (Spain) and has a strong background in studying human genetic variation and rare neurodevelopment disorders.

  • Miratul Muqit

    Dr Miratul Muqit is a Professor in the MRC Protein Phosphorylation and Ubiquitylation Unit, University Dundee, and a Wellcome Trust Senior Fellow. He studied Medicine at the University of Edinburgh and was a graduate student with Nicholas Wood at UCL Institute of Neurology where he contributed to the discovery of PINK1 mutations as a cause of Parkinson's. He was elected Fellow of the Royal Society of Edinburgh in 2020.

  • Alexandra Nelson, MD, PhD

    Alexandra Nelson, MD, PhD, is a systems neuroscientist and movement disorders neurologist. Her research is focused on the cellular and circuit bases of motor control, and in particular how these go awry in the context of movement disorders, such as Parkinson’s disease and dyskinesias. She is known for her expertise in ex vivo (slice) and in vivo electrophysiology, as well as her use of optogenetics and other cell type-specific tools. She has made contributions to our understanding of the cellular and circuit mechanisms of motor learning, as well as the function of basal ganglia microcircuits. In the context of disease, her laboratory has identified key basal ganglia physiological correlates of disease symptoms and effective therapies (such as dopamine replacement therapy and deep brain stimulation) in mouse models of Parkinson’s disease.

  • Raja Sekhar Nirujogi, PhD

    Raja is an Independent Investigator at Medical Research Council Protein Phosphorylation and Ubiquitylation Unit at University of Dundee. He contributed to the identification of LRRK2 kinase substrates and developed targeted mass spectrometry assays and organelle proteomic methodologies. His current research is focused on applying single cell proteomic methodologies to better understand PD brain disease heterogeneity.

  • Suzanne Pfeffer, PhD

    Suzanne Pfeffer is a Professor in the Department of Biochemistry at Stanford University School of Medicine. She studied synaptic vesicle recycling as a graduate student with Regis Kelly at UCSF and membrane trafficking with James Rothman as a postdoc at Stanford. She is a Fellow of the American Academy of Arts and Sciences, the American Association for the Advancement of Science, the American Society for Cell Biology (ASCB), and Past President of ASCB and the American Society for Biochemistry and Molecular Biology.

  • Sjors Scheres, PhD

    Sjors is a group leader at the MRC Laboratory of Molecular Biology in Cambridge, UK, where he also jointly heads the Structural Studies Division with Lori Passmore. He studied Chemsitry at Utrecht University in The Netherlands, and he did a postdoc at the Centro Nacional de Biotecnologia in Madrid Spain, before setting up his group in Cambridge. He is a fellow of the UK Royal Society and the UK Academy of Medical Sciences.

  • Amanda Schneeweis, PhD

    Amanda is the program manager for Team Awatramani! Her background is in Alzheimer's disease research but is very excited to contribute to the PD field! Amanda is based in Chicago, IL.

  • James Surmeier, PhD

    D. James Surmeier, PhD, is the Nathan Smith Davis Professor and Chair of the Department of Neuroscience at the Feinberg School of Medicine at Northwestern University. He studied mathematics as an undergraduate at the University of Idaho and received his PhD in Physiology and Biophysics at the University of Washington. He pioneered the use of advanced electrophysiological, optical, and molecular approaches to unravel the roles of dopamine and acetylcholine in modulating the striatal circuitry implicated in Parkinson’s disease. These studies have yielded fundamental insights into how striatal circuits adapt to the disease and how they contribute to side-effects of symptomatic treatment. In addition, Dr. Surmeier’s group has made a significant contribution to our understanding of how the physiology of dopaminergic neurons leads to the mitochondrial oxidant stress implicated in Parkinson’s disease pathogenesis. These studies have served as a foundation for large-scale clinical trials aimed at slowing Parkinson’s disease progression.

  • Patrick Cullinane, MD, PhD

    Patrick is a Senior Clinical Research Fellow at UCL Queen Square Institute of Neurology and an Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, specialising in movement disorders. He completed the Edmond J. Safra Fellowship in Movement Disorders at UCL. His research examines the biological basis of clinical and pathological heterogeneity in Parkinson’s disease and related disorders, including α-synuclein strain diversity and mechanisms of selective regional vulnerability. His work integrates human neuropathology with AI-based extraction of longitudinal clinical information from health records, spatial molecular profiling, data-driven modelling, and cellular models to define biologically meaningful disease subtypes, identify biomarkers and uncover therapeutic targets. His research is supported by competitive funding as Principal Investigator.

  • Lucy Jobbins

    Lucy is a Project Manager based in the Sharott Group at the University of Oxford. Lucy has worked in neurodegenerative disease research for over 8-years, starting out in NHS memory clinics. She has a BSc in Psychology from the University of Kent and an MSc in Neuroscience from the University of Sussex. She worked as a Research Assistant on a large dementia risk cohort study, the Heart-Brain Study at the University of Oxford. She then went on to complete a PhD in sleep and circadian rhythm disruption in dementia risk at the University of Oxford, where she conducted home-based polysomnography testing in healthy participants and people with MCI. Lucy is dedicated to ensuring lived experiences shape research and research outreach, and was awarded the Good Citizen Award for Patient and Public Engagement by the Oxford Centre for Integrative Neuroimaging.

  • Elsa Dean-Muncie, MSc

    Elsa is the project manager and incoming trainee in the Nelson Lab. She attended Williams College and studied biology and neuroscience. After Williams, she went on the complete a master's degree in Clinical Neuroscience in London.

  • Ioanna Armata, PhD

    Ioanna is the Project Manager for Team Doxakis at the Biomedical Research Foundation of the Academy of Athens, specializing in gene regulation & translational assay development. During her graduate studies at the Mount Sinai School of Medicine, she identified cis-regulatory elements in dystonia genes & worked with the first dystonia mouse model. She then joined Mass General Hospital & Harvard Medical School as a postdoctoral fellow & instructor, where she investigated torsinA's role in dystonia and exploring non-coding variants as biomarkers. As research faculty at Florida State University, she studied uORF-mediated regulation & developed HTS assays for uORF readthrough compounds. Later, she orchestrated research at the Atlantic Cancer Research Institute & L.-Dumont University Hospital Centre, focusing on neurological disease-associated variants, patient-derived cell lines & drug-repurposing assays. Prior to her current role, she worked at ProteofosDx & lectured at Aegean College

  • Matthieu Gobin, PhD

    Matthieu has a PhD in Molecular Biology and worked during his PhD thesis on cancer biology. He is now working in a laboratory doing research on Parkinson's disease using advanced in vitro cellular models, namely brain organoids. Since 7 years, he writes project for different national and international funding calls. Nowadays he is integrating data analysis using computational analysis into his workflow.

  • Andrew Sharott, PhD

    Andrew is a Professor of Neuroscience at the University of Oxford and Associate Director of the MRC Center of Excellence in Restorative Neural Dynamics. He studied the role of neural oscillations in movement disorders as a PhD student with Peter Brown at the Institute of Neurology, University College London.

Load More
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.